These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 8134110)

  • 1. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
    Yamit-Hezi A; Plaksin D; Eisenbach L
    Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I genes controlling the metastatic phenotype of tumor cells.
    Feldman M; Eisenbach L
    Semin Cancer Biol; 1991 Oct; 2(5):337-46. PubMed ID: 1773049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
    Mandelboim O; Feldman M; Eisenbach L
    J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes.
    Kushtai G; Barzilay J; Feldman M; Eisenbach L
    Oncogene; 1988 Feb; 2(2):119-27. PubMed ID: 2453011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
    Alon Y; Hammerling GJ; Segal S; Bar-Eli M
    Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
    Li M; Muller J; Xu F; Hearing VJ; Gorelik E
    Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A protein.
    Brockmann D; Schäfer D; Kirch HC; Esche H
    Oncogene; 1996 Apr; 12(8):1715-25. PubMed ID: 8622892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.
    Porgador A; Bannerji R; Watanabe Y; Feldman M; Gilboa E; Eisenbach L
    J Immunol; 1993 Feb; 150(4):1458-70. PubMed ID: 8432988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a transfected H-2Kb gene in B16 cells correlates with suppression of liver metastases in triple immunodeficient mice.
    Calorini L; Marozzi A; Byers HR; Waneck GL; Lee KW; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1992 Jul; 52(14):4036-41. PubMed ID: 1617680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.
    Porgador A; Tzehoval E; Katz A; Vadai E; Revel M; Feldman M; Eisenbach L
    Cancer Res; 1992 Jul; 52(13):3679-86. PubMed ID: 1617640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-fos transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence.
    Kushtai G; Feldman M; Eisenbach L
    Int J Cancer; 1990 Jun; 45(6):1131-6. PubMed ID: 2351488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun.
    Marshall-Heyman H; Engel G; Ljungdahl S; Shoshan MC; Svensson C; Wasylyk B; Linder S
    Oncogene; 1994 Dec; 9(12):3655-63. PubMed ID: 7970724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos.
    Wang ZQ; Liang J; Schellander K; Wagner EF; Grigoriadis AE
    Cancer Res; 1995 Dec; 55(24):6244-51. PubMed ID: 8521421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
    Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
    Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.